APA (7th ed.) Citation

Lecka-Czernik, B., Ackert-Bicknell, C., Adamo, M. L., Marmolejos, V., Churchill, G. A., Shockley, K. R., . . . Rosen, C. J. (2007). Activation of Peroxisome Proliferator-Activated Receptor γ (PPARγ) by Rosiglitazone Suppresses Components of the Insulin-Like Growth Factor Regulatory System in Vitro and in Vivo. Endocrinology (Philadelphia), 148(2), 903-911. https://doi.org/10.1210/en.2006-1121

Chicago Style (17th ed.) Citation

Lecka-Czernik, B., C. Ackert-Bicknell, M. L. Adamo, V. Marmolejos, G. A. Churchill, K. R. Shockley, I. R. Reid, A. Grey, and C. J. Rosen. "Activation of Peroxisome Proliferator-Activated Receptor γ (PPARγ) by Rosiglitazone Suppresses Components of the Insulin-Like Growth Factor Regulatory System in Vitro and in Vivo." Endocrinology (Philadelphia) 148, no. 2 (2007): 903-911. https://doi.org/10.1210/en.2006-1121.

MLA (9th ed.) Citation

Lecka-Czernik, B., et al. "Activation of Peroxisome Proliferator-Activated Receptor γ (PPARγ) by Rosiglitazone Suppresses Components of the Insulin-Like Growth Factor Regulatory System in Vitro and in Vivo." Endocrinology (Philadelphia), vol. 148, no. 2, 2007, pp. 903-911, https://doi.org/10.1210/en.2006-1121.